Skip to main content

Table 3 List of significant modulated genes (p < 0.05) expressed in the muscles suffering from PSSM.

From: Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions

Gene name

EST – Sequence

Entrez Gene

Normalized ratio

P-value < 0.05

IL18

Y11131

3606

6.20

1.58E-03

CTSS

CD464451

1520

3.17

3.24E-03

LUM

CX594607

4060

3.15

8.40E-04

CD44

CD464887

960

2.42

9.56E-04

FN1

ECU52108

2335

2.17

5.10E-03

GSTO1

CX603867

9446

2.03

2.64E-03

VCAM1

CX602484

7412

1.98

2.76E-02

ITGB1

CX598727

3688

1.87

2.31E-03

CXCR4

CD466324

7852

1.81

2.74E-02

HIF1A

CX602270

3091

1.73

1.36E-03

ITGB2

CD535228

3689

1.70

4.26E-04

HSPA5

CX604607

3309

1.69

1.42E-02

GNAS

BM734975

2778

1.63

1.45E-03

CD69

CD528606

969

1.62

2.67E-02

LTF

ECA010930

4057

1.58

1.73E-02

GSK3B

CX592808

2932

1.50

2.60E-03

APP

CX601350

351

1.40

1.04E-02

CAT

CD464332

847

1.39

6.36E-03

ENO1

CX603657

2023

1.39

7.60E-03

VAV1

BI961759

7409

1.37

2.70E-03

MYLK

CX592941

4638

1.35

5.21E-02

EPO

AB100030

2056

1.34

6.91E-03

IL15

AY682849

3600

1.34

4.57E-03

ITGAL

CD464254

3683

1.32

1.32E-02

CD40

AY514017

958

1.30

4.73E-02

ACTN2

AB178951

88

1.29

1.76E-02

GDF8

AB033541

2660

1.29

4.87E-02

DAG1

CX600578

1605

1.28

1.20E-02

IGF2

U11241

3481

1.28

2.61E-02

HCK

BM734694

3055

1.27

2.45E-02

ACAA2

CX603916

10449

1.25

1.67E-02

COMT

AB178284

1312

1.23

4.70E-04

FLII

CX604876

2314

1.21

2.73E-02

ATP5a1

DN509143

498

1.21

5.18E-02

MYL9

CX594102

10398

1.18

1.56E-02

CCL13

ECA251188

6357

1.17

1.04E-02

GJA5

AY008788

2702

1.07

5.07E-02

ATP5C1

CX593263

509

0.90

4.87E-02

PYGL

CX597788

5836

0.90

2.66E-02

FGR

CD470584

2268

0.88

4.71E-02

MRPL49

CD469126

740

0.87

5.00E-02

GOT2

CX602317

2806

0.87

4.82E-02

ALOX5AP

CD536322

241

0.86

1.95E-02

IMMT

CX597479

10889

0.85

4.56E-02

ECHS1

CX604357

1892

0.85

4.05E-03

SLC2A1

DQ139875

6513

0.85

6.96E-03

CYTB

X79547

4519

0.85

1.98E-02

EDN1

AY730629

1906

0.84

4.03E-02

PNMT

AB071422

5409

0.84

2.08E-03

IL7

CX592622

3574

0.84

4.32E-02

IDH2

CX604713

3418

0.83

1.09E-02

PTGER4

DN505656

5734

0.83

1.72E-05

IL6ST

DN507511

3572

0.83

4.34E-04

SCN4A

ECU25990

6329

0.82

3.11E-02

CEBPB

CX605423

1051

0.82

8.99E-03

SHMT2

CX605845

6472

0.82

2.08E-03

GLS

CX600244

2744

0.81

7.01E-03

CYP19A1

ECA012610

1588

0.81

3.23E-02

PLAU

CD471288

5328

0.81

3.89E-03

SLC25a5

DN506810

292

0.81

5.66E-03

ATP5o

DN509617

539

0.80

1.98E-02

NQO1

DN508254

1728

0.80

2.44E-04

FYN

CD528430

2534

0.78

1.17E-02

SLC8A1

DQ178640

6546

0.78

1.98E-03

HNRPK

CX598401

3190

0.77

4.69E-05

Leu-ARNt_TRNL1

X79547

4567

0.77

1.58E-03

MIF

CX599697

4282

0.77

1.05E-02

ND2

X79547

4536

0.76

3.34E-03

CYTB

X79547

4519

0.76

7.85E-03

OPRM1

ECA519535

4988

0.76

1.07E-04

CSF1

CD469550

1435

0.75

7.13E-04

RELB

CD472197

5971

0.75

5.86E-05

Met-ARNt_TRNM

X79547

4569

0.74

3.31E-03

SSPN

CX605718

8082

0.72

1.65E-02

COX 3

X79547

4514

0.72

5.08E-03

CPT2

CX599757

1376

0.72

1.49E-04

PDE4B

CD470720

5142

0.72

4.70E-06

ATP5e

DN509652

514

0.72

1.22E-02

NR3C1

CX597756

2908

0.72

1.89E-02

STAT6

CD467276

6778

0.72

1.91E-02

ND2

X79547

4536

0.72

1.09E-04

COX 3

X79547

4514

0.70

2.46E-03

ND6

X79547

4541

0.70

4.69E-05

OXTR

BM734870

5021

0.69

9.30E-04

ATP1B1

DN511201

481

0.69

2.20E-04

ATP5j

DN507306

522

0.69

4.03E-02

PLG

BM780461

5340

0.69

3.21E-04

COX 2

X79547

4513

0.69

1.03E-02

PKM2

CX604027

5315

0.69

1.82E-02

ATP5h

CX599509

10476

0.69

1.20E-03

ATP5d

CX603287

513

0.69

4.65E-04

CSF3

AF503365

1440

0.68

1.84E-05

Phe-ARNt_TRNF

X79547

4558

0.67

4.07E-05

Glu-ARNt_TRNE

X79547

4556

0.67

2.98E-06

TNFRSF4

CD465063

7293

0.66

6.88E-04

IGHE

ECA305046

3497

0.66

4.10E-05

ATP5l

CX603854

10632

0.66

4.69E-03

UCP2

CD528532

7351

0.66

8.40E-03

Lys-ARNt_TRNK

X79547

4566

0.65

1.60E-03

ND3

X79547

4537

0.64

1.12E-03

ND6

X79547

4541

0.63

7.60E-05

ATP2A1

AF489278

487

0.62

5.98E-04

TNFSF13B

CD470712

10673

0.62

1.95E-05

Gly-ARNt_TRNG

X79547

4563

0.62

4.97E-03

NFKBIB

CX601294

4793

0.59

9.31E-06

PLCG2

CX603458

5336

0.58

7.89E-08

ND5

X79547

4540

0.57

1.01E-05

ND3

X79547

4537

0.57

1.65E-05

SLC25a17

CX598253

10478

0.57

2.13E-06

SRI

DN506802

6717

0.57

4.60E-06

Val-ARNt_TRNV

X79547

4577

0.56

1.95E-04

Asp-ARNt_TRND

X79547

4555

0.55

1.76E-05

ND5

X79547

4540

0.54

1.39E-05

PDE4D

CX593241

5144

0.54

1.26E-06

Ser-ARNt_TRNS2

X79547

4575

0.50

6.05E-03

Ile-ARNt_TRNI

X79547

4565

0.49

1.21E-03

SLC25a15

CX598538

10166

0.48

4.95E-02

Leu-ARNt_TRNL2

X79547

4568

0.44

1.13E-05

Trp-ARNt_TRNW

X79547

4578

0.40

2.13E-06

Thr-ARNt_TRNT

X79547

4576

0.40

5.63E-05

Pro-ARNt_TRNP

X79547

4571

0.39

2.59E-06

VEGF

AB053350

7422

0.37

1.32E-06

PRKCA

CX602892

5578

0.37

2.18E-06

SLC2A2

AJ715983

6514

0.35

2.18E-06

Ala-ARNt_TRNA

X79547

4553

0.35

1.10E-04

Tyr-ARNt_TRNY

X79547

4579

0.35

1.04E-03

Asn-ARNt_TRNN

X79547

4570

0.33

8.13E-06

Cys-ARNt_TRNC

X79547

4511

0.28

4.48E-06

Gln-ARNt_TRNQ

X79547

4572

0.21

3.81E-07

  1. Significant p-value (p < 0.05) indicated that the expression ratio was significantly different from 1.
  2. P-values are expressed in scientific format: 1E-3 means 1.10-3.